Search
Throughout 2023, OSHA has implemented multiple policy changes meant to enhance its enforcement mechanisms, including increased funding and inspector hirings, revisions to the "instance-by-instance" violation policy, modifications to the Severe Violator Enforcement Program, and the new electronic...
Contractors could start seeing six-figure fines from the Occupational Safety and Health Administration (OSHA) in the next few months thanks to sweeping policy changes implemented earlier this year. In a press release and two internal memoranda issued January 26, 2023, the Department of Labor (DOL)...
What Do We Do Now?! How To Handle an OSHA Inspection An inspection from the Occupational Safety and Health Administration (OSHA) can affect a construction site in many ways—from workflow disruptions to compliance issues. In this seminar, Michael Metz-Topodas reviews the regulatory requirements...
"A Change Is Gonna Come" What OSHA's Policy Revisions May Mean for the Construction Industry Michael Metz-Topodas, a Partner in the firm's Construction Practice, will be speaking on a panel during the American Subcontractors Association of Central Pennsylvania Half-Day Construction Symposium...
The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...
Michael Metz-Topodas represents clients in construction-related litigation and disputes and counsels them on construction law matters. His practice also focuses on Occupational Safety and Health Administration (OSHA) regulatory compliance and citation defense for construction and industrial clients...
Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...
Sarah Sullivan represents pharmaceutical companies involved in complex, high stakes patent litigation. Sarah concentrates her practice on Hatch-Waxman ANDA cases and disputes over the intellectual property behind branded pharmaceuticals. She is part of the Firm's nationally-recognized team for...
Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...
Alex Callo represents clients in high stakes intellectual property litigation, with a specific focus on complex pharmaceutical patent litigation under the Hatch-Waxman Act. His experience includes drafting motions and pleadings, research, and analyzing discovery. Alex has a background in both...
Bill Baton represents pharmaceutical companies in complex, often high-profile, patent litigation. Bill concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical companies. He currently serves as New Jersey litigation counsel in more...
Rob Duston is a business lawyer and litigator with more than 30 years of experience helping businesses, schools and other entities, primarily in three areas of the law: compliance with the public access requirements of the Americans with Disabilities Act (ADA), Fair Housing Act (FHA), Section 504 of...